China Biologic Products (CBPO) Reports Q3 EPS of $0.96
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
China Biologic Reports Financial Results for the Third Quarter of 2018
November 1, 2018 4:30 PM EDT3Q18 Total Sales Up 21.9% YoY in RMB terms, or 19.6% YoY in USD terms;
Non-GAAP Adjusted Net Income Down 12.7% YoY in RMB terms;
Net Income Up 4.1% YoY to $32.9 Million
Board of Directors Approves $100 Million Share Repurchase Program
BEIJING, Nov. 1, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading... More
